Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT1308 in Advanced Solid Tumors
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
A phase I dose escalation and cohort expansion study to evaluate the safety, tolerance and
pharmacokinetic of BAT1308 injection in patients with advanced solid tumors